Liberate Medical received a $6.5M grant funding from the US Department of Defense to commence the PREVENT trial, a global collaborative effort examining the VentFree Respiratory Muscle Stimulator.

Liberate Medical is a medical device company pioneering neuromuscular electrical stimulation technology to improve care for patients with pulmonary disorders. Its lead product, the VentFree™ respiratory muscle stimulator, delivers proprietary, non-invasive stimulation to the expiratory muscles in synchrony with exhalation during mechanical ventilation. This breakthrough therapy is designed to reduce abdominal muscle atrophy, shorten time on ventilators, and ultimately improve outcomes, enhance quality of life, and lower healthcare costs.

liberatemedical.com

Medical

Health Care

Liberate Medical receives $6.5M grant funding from the US DoD for PREVENT trial

Description

Company Information

Related People

Liberate Medical receives $6.5M grant funding from the US DoD for PREVENT trial

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information